NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 36 filers reported holding NEUBASE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $12,707 | -51.4% | 68,687 | -50.0% | 0.00% | – |
| Q4 2022 | $26,128 | -3.2% | 137,374 | +100.0% | 0.00% | – |
| Q3 2022 | $27,000 | -62.5% | 68,687 | 0.0% | 0.00% | – |
| Q2 2022 | $72,000 | -44.2% | 68,687 | 0.0% | 0.00% | – |
| Q1 2022 | $129,000 | -20.9% | 68,687 | +18.4% | 0.00% | – |
| Q4 2021 | $163,000 | -22.0% | 58,013 | 0.0% | 0.00% | – |
| Q3 2021 | $209,000 | +83.3% | 58,013 | +143.6% | 0.00% | – |
| Q2 2021 | $114,000 | -94.0% | 23,813 | -90.8% | 0.00% | – |
| Q1 2021 | $1,908,000 | +6.9% | 258,126 | +1.1% | 0.00% | – |
| Q4 2020 | $1,785,000 | -15.3% | 255,390 | -8.0% | 0.00% | – |
| Q3 2020 | $2,107,000 | -3.5% | 277,645 | +11.6% | 0.00% | – |
| Q2 2020 | $2,184,000 | – | 248,795 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $494,000 | 0.50% |
| CARNEGIE MELLON UNIVERSITY | 939,412 | $986,000 | 0.50% |
| CM Management, LLC | 370,000 | $389,000 | 0.41% |
| Decheng Capital Management III (Cayman), LLC | 1,000,000 | $1,050,000 | 0.40% |
| Sio Capital Management, LLC | 906,445 | $952,000 | 0.36% |
| AIGH Capital Management LLC | 1,027,585 | $1,079,000 | 0.28% |
| Greenlight Capital | 2,727,027 | $2,863,000 | 0.22% |
| Worth Venture Partners, LLC | 256,553 | $249,000 | 0.15% |
| PERKINS CAPITAL MANAGEMENT INC | 81,500 | $86,000 | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $327,000 | 0.01% |